Oslo, Norway, 11 August 2022
Vistin Pharma ASA will release its second quarter and YTD 2022 results on Friday 19th of August 2022. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Friday 19th of August at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in English.
The second quarter conference call will be available via webcast and audio through the following access points:
Webcast:
https://edge.media-server.com/mmc/p/m83myj4s
Telephone conference (online registration):
https://register.vevent.com/register/BI3e5ac1165d974dacab56dd8f81b4fba4
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well–positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.
Key Commercialization Milestone in Retail Pharmacy Network that Serves Over 2.8 Million Insured MembersVancouver, British…
Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…
Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF-BY-THE-SEA, Calif., Feb. 5,…
SAN JOSE, Calif., Feb. 5, 2026 /PRNewswire/ -- LEADOPTIK, Inc., a medical technology company focused…
Now Available for Purchase, AirBoss Delivers an NFPA 1970:2025 SCBA Built for the Way American…
KLAS recognition highlights Greenway's momentum in modernizing physician practice technologyTAMPA, Fla., Feb. 5, 2026 /PRNewswire/…